Last $61.78 USD
Change Today +0.23 / 0.37%
Volume 1.3M
ALB On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

albemarle corp (ALB) Snapshot

Open
$62.47
Previous Close
$61.55
Day High
$62.54
Day Low
$61.52
52 Week High
07/15/14 - $76.28
52 Week Low
10/15/14 - $51.35
Market Cap
4.8B
Average Volume 10 Days
1.5M
EPS TTM
$5.23
Shares Outstanding
78.3M
EX-Date
12/11/14
P/E TM
11.8x
Dividend
$1.10
Dividend Yield
1.72%
Current Stock Chart for ALBEMARLE CORP (ALB)

albemarle corp (ALB) Related Businessweek News

No Related Businessweek News Found

albemarle corp (ALB) Details

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals. It provides brominated and mineral based flame retardants under the Saytex, Martinal, and Magnifin brands that are used in plastic enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles, and foam insulation; and plastic and other additives, such as curatives, antioxidants, and stabilizers under the Ethacure and Ethanox brands. The company also offers refinery catalysts, including hydroprocessing catalysts, fluidized catalytic cracking catalysts, and additives; organometallic co-catalysts and metallocene components and co-catalysts; electronic materials, such as high purity metal organic products, as well as other products; and chemical catalysts used in the chemical industry, as well as provides single-site catalysts and Ziegler-Natta catalysts under the Advantage brand. In addition, the company provides elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications, as well as tertiary amines for surfactants, biocides, disinfectants, and sanitizers; and aluminum oxides for use in various refractory, ceramic and polishing applications. Further, it supplies fine chemistry products and performance chemicals for pharmaceutical and agricultural use, as well as provides custom manufacturing, research, and chemical scale-up services for companies. The company serves petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety, and custom chemistry service markets. Albemarle Corporation was founded in 1993 and is headquartered in Baton Rouge, Louisiana.

4,231 Employees
Last Reported Date: 02/25/14
Founded in 1993

albemarle corp (ALB) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $800.0K
Chief Financial Officer, Chief Risk Officer a...
Total Annual Compensation: $443.8K
Senior Vice President and President of Perfor...
Total Annual Compensation: $315.0K
Senior Vice President and President of Cataly...
Total Annual Compensation: $106.6K
Senior Vice President, General Counsel of Cor...
Total Annual Compensation: $397.0K
Compensation as of Fiscal Year 2013.

albemarle corp (ALB) Key Developments

Albemarle to Increase Production Capacity in Pasadena, Texas for its Curative Products

Albemarle Corporation announced that it plans to increase production capabilities of its curatives products at its facility in Pasadena, Texas. The capacity investment will support Albemarle's ETHACURE(R) 100 liquid curative product for application in polyureas, urethanes and epoxies. Albemarle's ETHACURE 100 curatives are effective curing agents and chain extenders for polyurethane and polyurea elastomers, as well as epoxy resins, particularly in reaction injection molding and spray applications. These diamine curatives allow for adjustable reaction time and substantially reduce dust exposure while providing processing advantages and improved final product properties. Production in the expanded facility is expected in 2015.

Albemarle Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Tax Rate Guidance for the Full Year 2014

Albemarle Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net sales of $642,418,000 against $591,196,000 for the same period in the last year. Operating profit was $106,473,000 against $128,802,000 for the same period in the last year. Income from continuing operations before income taxes and equity in net income of unconsolidated investments was $91,106,000 against $118,938,000 for the same period in the last year. Net income from continuing operations was $88,019,000 or $1.01 per diluted share against $97,313,000 or $1.10 per diluted share for the same period in the last year. Net income attributable to the company was $72,794,000 or $0.93 per diluted share against $90,512,000 or $1.11 per diluted share for the same period in the last year. Adjusted net income attributable to the company was $89,466,000 against $88,860,000 for the same period in the last year. EBITDA was $117,837,000 against $154,942,000 for the same period in the last year. Adjusted EBITDA was $144,604,000 against $149,230,000 for the same period in the last year. Adjusted diluted earnings per share were $1.14 against $1.09 for the same period in the last year. Net sales in the third quarter of 2014 were mainly driven by higher volumes across Catalyst Solutions and bromine products due to strong market demand and favorable pricing in Catalyst Solutions. CapEx was $30 million. Net debt, excluding non-guaranteed JV debt, ended the period at $393 million. Effective tax rate, excluding special items, nonoperating pension and OPEB items was 18.9%. For the nine months, the company reported net sales of $1,846,982,000 against $1,754,635,000 for the same period in the last year. Operating profit was $294,636,000 against $349,565,000 for the same period in the last year. Income from continuing operations before income taxes and equity in net income of unconsolidated investments was $261,927,000 against $321,083,000 for the same period in the last year. Net income from continuing operations was $243,427,000 or $2.78 per diluted share against $273,494,000 or $2.96 per diluted share for the same period in the last year. Net income attributable to the company was $151,824,000 or $1.91 per diluted share against $257,238,000 or $3.02 per diluted share for the same period in the last year. Capital expenditures were $76,682,000 against $135,028,000 for the same period in the last year. Adjusted net income attributable to the company was $254,714,000 against $248,879,000 for the same period in the last year. EBITDA was $281,157,000 against $433,966,000 for the same period in the last year. Adjusted EBITDA was $425,322,000 against $412,509,000 for the same period in the last year. Year to date cash flow from operations were $430.5 million, up 36% versus 2013 on lower working capital. Adjusted diluted earnings per share were $3.21 against $2.92 for the same period in the last year. Net sales for the nine months ended September 30, 2014 were mainly driven by favorable Catalyst Solutions pricing and volumes on strong demand, and the favorable impact of a stronger European Union Euro, partly offset by lower pricing in Performance Chemicals. The company expects full year tax rate to be 21.7%, driven by the favorable mix of income and lower tax jurisdictions.

Albemarle Corporation Declares Quarterly Dividend, Payable on January 2, 2015

The board of directors of Albemarle Corporation declared a quarterly dividend of $0.275 per share. The dividend is payable January 2, 2015, to shareholders of record at the close of business as of December 15, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALB:US $61.78 USD +0.23

ALB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,483 GBp +49.00
Cytec Industries Inc $48.94 USD +0.19
Kyowa Hakko Kirin Co Ltd ¥1,302 JPY +24.00
Lonza Group AG SFr.108.30 CHF +1.40
Rockwood Holdings Inc $79.06 USD +0.22
View Industry Companies
 

Industry Analysis

ALB

Industry Average

Valuation ALB Industry Range
Price/Earnings 12.9x
Price/Sales 1.8x
Price/Book 3.3x
Price/Cash Flow 15.7x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALBEMARLE CORP, please visit www.albemarle.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.